Landsberg Bennett & Dubbaneh’s Boston Scientific BSX Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$804K	Sell	18,354 -9,362	-34%	-$414K	0.1%	135
2021 Q2	$1.2M	Buy	27,716 +1,114	+4%	+$46.9K	0.16%	118
2021 Q1	$1.03M	Buy	26,602 +6,499	+32%	+$246K	0.15%	117
2020 Q4	$723K	Buy	20,103 +13,864	+222%	+$500K	0.11%	123
2020 Q3	$236K	Sell	6,239 -1,020	-14%	-$39.3K	0.04%	185
2020 Q2	$252K	Buy	+7,259	New	+$261K	0.05%	175

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's BSX Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its Boston Scientific (BSX) stake by 34% in Q3 2021, selling an estimated $414K and leaving 18,354 shares worth $804K. The position accounts for 0.1% of the portfolio, ranked #135.

Landsberg Bennett & Dubbaneh first reported a position in BSX in Q2 2020 and has held it in 6 quarters since. The position peaked at $1.2M in Q2 2021. 878 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

Landsberg Bennett & Dubbaneh held 18,354 shares of Boston Scientific worth $804K as of Q3 2021.
Landsberg Bennett & Dubbaneh sold 9,362 Boston Scientific shares in Q3 2021, an estimated $414K.
Boston Scientific made up 0.1% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #135 holding.
Landsberg Bennett & Dubbaneh first reported a position in Boston Scientific in Q2 2020 and has held it in 6 quarters since.
Landsberg Bennett & Dubbaneh's Boston Scientific position peaked at $1.2M in Q2 2021.
878 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.